Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2018

Open Access 01-12-2018 | Commentary

Upcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology

Authors: Paul Russell Roberts, Ashesh B. Jani, Satyaseelan Packianathan, Ashley Albert, Rahul Bhandari, Srinivasan Vijayakumar

Published in: Radiation Oncology | Issue 1/2018

Login to get access

Abstract

For 2018, the American Cancer Society estimated that there would be approximately 1.7 million new diagnoses of cancer and about 609,640 cancer-related deaths in the United States. By 2030 these numbers are anticipated to exceed a staggering 21 million annual diagnoses and 13 million cancer-related deaths. The three primary therapeutic modalities for cancer treatments are surgery, chemotherapy, and radiation therapy. Individually or in combination, these treatment modalities have provided and continue to provide curative and palliative care to the myriad victims of cancer.
Today, CT-based treatment planning is the primary means through which conventional photon radiation therapy is planned. Although CT remains the primary treatment planning modality, the field of radiation oncology is moving beyond the sole use of CT scans to define treatment targets and organs at risk. Complementary tissue scans, such as magnetic resonance imaging (MRI) and positron electron emission (PET) scans, have all improved a physician’s ability to more specifically identify target tissues, and in some cases, international guidelines have even been issued. Moreover, efforts to combine PET and MR to define solid tumors for radiotherapy planning and treatment evaluation are also gaining traction.
Keeping these advances in mind, we present brief overviews of other up-and-coming key imaging concepts that appear promising for initial treatment target definition or treatment response from radiation therapy.
Literature
1.
Coleman CN, et al. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Front Oncol. 2014;4:333.CrossRefPubMedPubMedCentral
2.
ICRU Prescribing, Recording and reporting photon beam therapy (supplement to ICRU report 50), ICRU report 62. 1999.
3.
ICRU Prescribing, Recording, and reporting photon beam therapy (report 50), ICRU report 50. ICRU, 1978.
4.
Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71(2):201–6.CrossRefPubMed
5.
Metcalfe P, et al. The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat. 2013;12(5):429–46.CrossRefPubMed
6.
7.
Awan MJ, et al. Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers. World J Radiol. 2015;7(11):382–93.CrossRefPubMedPubMedCentral
8.
Lee P, et al. Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer. Front Oncol. 2012;2:71.PubMedPubMedCentral
9.
Boellard R, Delgado-Bolton R, WJG O, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging – version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef
10.
Balyasnikova S, et al. PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging. 2012;2(4):458–74.PubMedPubMedCentral
11.
Vali R, et al. Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine. Am J Nucl Med Mol Imaging. 2015;5(2):96–108.PubMedPubMedCentral
12.
Af M, Rosenschold P, et al. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma. Neuro Oncol. 2015;17(5):757–63.CrossRef
13.
Visgauss JD, Eward WC, Brigman BE. Innovations in intraoperative tumor visualization. Orthop Clin North Am. 2016;47(1):253–64.CrossRefPubMed
14.
Moriichi K, Fujiya M, Okumura T. The efficacy of autofluorescence imaging in the diagnosis of colorectal diseases. Clin J Gastroenterol. 2016;9(4):175–83.CrossRefPubMed
15.
Chamma E, et al. Optically-tracked handheld fluorescence imaging platform for monitoring skin response in the management of soft tissue sarcoma. J Biomed Opt. 2015;20(7):076011.CrossRefPubMed
16.
Reznicek L, et al. Role of wide-field autofluorescence imaging and scanning laser ophthalmoscopy in differentiation of choroidal pigmented lesions. Int J Ophthalmol. 2014;7(4):697–703.PubMedPubMedCentral
17.
Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013;27(2):208–16.CrossRef
18.
Damato B. Progress in the management of patients with uveal melanoma. The 2012 Ashton lecture. Eye (Lond). 2012;26(9):1157–72.CrossRef
19.
Nguyen PT, et al. Combining autofluorescence and narrow band imaging with image analysis in the evaluation of preneoplastic lesions in the bronchus and larynx. J Bronchology Interv Pulmonol. 2010;17(2):109–16.CrossRefPubMed
20.
Keller MD, et al. Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis. Lasers Surg Med. 2010;42(1):15–23.CrossRefPubMed
21.
Herth FJ, Eberhardt R, Ernst A. The future of bronchoscopy in diagnosing, staging and treatment of lung cancer. Respiration. 2006;73(4):399–409.CrossRefPubMed
22.
Schols RM, Connell NJ, Stassen LP. Near-infrared fluorescence imaging for real-time intraoperative anatomical guidance in minimally invasive surgery: a systematic review of the literature. World J Surg. 2015;39(5):1069–79.CrossRefPubMed
23.
Zhu B, Sevick-Muraca EM. A review of performance of near-infrared fluorescence imaging devices used in clinical studies. Br J Radiol. 2015;88:1045.CrossRef
24.
Neuman BP, et al. Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer. Clin Cancer Res. 2015;21(4):771–80.CrossRefPubMed
25.
Pleijhuis RG, et al. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol. 2011;37(1):32–9.CrossRefPubMed
26.
Leblond F, et al. Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications. J Photochem Photobiol B. 2010;98(1):77–94.CrossRefPubMed
27.
Hariri G, et al. Multifunctional FePt nanoparticles for radiation-guided targeting and imaging of cancer. Ann Biomed Eng. 2011;39(3):946–52.CrossRefPubMed
28.
Souris JS, et al. Radioluminescence characterization of in situ x-ray nanodosimeters: potential real-time monitors and modulators of external beam radiation therapy. Appl Phys Lett. 2014;105(20):203110.CrossRefPubMedPubMedCentral
29.
Bertrand N, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.CrossRefPubMed
30.
Wakabayashi H, et al. Fundamental and clinical studies on fluorescence laparoscopy after intravenous injection of fluorescein-sodium. Gastroenterol Jpn. 1989;24(6):676–84.CrossRefPubMed
31.
Whitley MJ, Weissleder R, Kirsch DG. Tailoring adjuvant radiation therapy by intraoperative imaging to detect residual Cancer. Semin Radiat Oncol. 2015;25(4):313–21.CrossRefPubMedPubMedCentral
32.
Ambrosini V, et al. Radiopeptide imaging and therapy in Europe. J Nucl Med. 2011;52(Suppl 2):42S–55S.CrossRefPubMed
33.
van Waarde A, et al. Potential applications for sigma receptor ligands in cancer diagnosis and therapy. Biochim Biophys Acta. 2015;1848(10 Pt B):2703–14.CrossRefPubMed
34.
Allweis TM, et al. A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg. 2008;196(4):483–9.CrossRefPubMed
35.
van den Bergen B, et al. Uniform prostate imaging and spectroscopy at 7 T: comparison between a microstrip array and an endorectal coil. NMR Biomed. 2011;24(4):358–65.PubMed
36.
Raman CV, K K. A new type of secondary radiation. Nature. 1928;121(501)
37.
Devpura S, et al. Vision 20/20: the role of Raman spectroscopy in early stage cancer detection and feasibility for application in radiation therapy response assessment. Med Phys. 2014;41(5):050901.CrossRefPubMed
38.
Kast RE, et al. Emerging technology: applications of Raman spectroscopy for prostate cancer. Cancer Metastasis Rev. 2014;33(2–3):673–93.CrossRefPubMed
39.
40.
41.
42.
Camus VL, et al. Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors. Analyst. 2016;141(17):5056–61.CrossRefPubMed
43.
Harder SJ, et al. A Raman spectroscopic study of cell response to clinical doses of ionizing radiation. Appl Spectrosc. 2015;69(2):193–204.CrossRefPubMed
44.
Yasser M, et al. Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation. PLoS One. 2014;9(5):e97777.CrossRefPubMedPubMedCentral
45.
Matthews Q, et al. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy. Phys Med Biol. 2011;56(21):6839–55.CrossRefPubMed
46.
Zhu C, et al. Diagnosis of breast cancer using fluorescence and diffuse reflectance spectroscopy: a Monte-Carlo-model-based approach. J Biomed Opt. 2008;13(3):034015.CrossRefPubMed
47.
Bigio IJ, et al. Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. J Biomed Opt. 2000;5(2):221–8.CrossRefPubMed
48.
Dhar A, et al. Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. Gastrointest Endosc. 2006;63(2):257–61.CrossRefPubMed
49.
Lin WC, et al. In vivo optical spectroscopy detects radiation damage in brain tissue. Neurosurgery. 2005;57(3):518–25. discussion 518-25CrossRefPubMed
50.
Sunar U, et al. Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study. J Biomed Opt. 2006;11(6):064021.CrossRefPubMed
51.
Nagle SM, et al. Challenges and regulatory considerations in the acoustic measurement of high-frequency (>20 MHz) ultrasound. J Ultrasound Med. 2013;32(11):1897–911.CrossRefPubMed
52.
Doyle TE, et al. High-frequency ultrasound for intraoperative margin assessments in breast conservation surgery: a feasibility study. BMC Cancer. 2011;11:444.CrossRefPubMedPubMedCentral
53.
Ramos M, et al. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. Breast. 2013;22(4):520–4.CrossRefPubMed
54.
Kwok SJ, et al. Ultrasound-mediated microbubble enhancement of radiation therapy studied using three-dimensional high-frequency power Doppler ultrasound. Ultrasound Med Biol. 2013;39(11):1983–90.CrossRefPubMed
55.
Adriaenssens N, et al. Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy. Radiol Oncol. 2012;46(4):284–95.CrossRefPubMedPubMedCentral
56.
Huang YP, et al. High frequency ultrasound assessment of skin fibrosis: clinical results. Ultrasound Med Biol. 2007;33(8):1191–8.CrossRefPubMed
57.
Wratten CR, et al. Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound. Breast J. 2007;13(3):266–73.CrossRefPubMed
58.
Daftari I, et al. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation. Phys Med Biol. 2001;46(2):579–90.CrossRefPubMed
59.
Yang X, R P, Ogunleye T, Jani a, Curran W, Liu T. MR-US Prostate Registration Using Patient-Specific Tissue Elasticity Property Prior for MR-Targeted, TRUS-Guided HDR Brachytherapy. Med Phys. 2014;41(6):470–1.CrossRef
60.
Claudon M, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008;29(1):28–44.CrossRefPubMed
61.
Madsen HH, Rasmussen F. Contrast-enhanced ultrasound in oncology. Cancer Imaging. 2011; 11 Spec No A: p. S167–73
62.
Xie L, et al. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol. 2011;37(6):854–61.CrossRefPubMed
63.
Kedar RP, et al. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology. 1996;198(3):679–86.CrossRefPubMed
64.
Balleyguier C, et al. New potential and applications of contrast-enhanced ultrasound of the breast: own investigations and review of the literature. Eur J Radiol. 2009;69(1):14–23.CrossRefPubMed
65.
Catalano O, et al. Contrast-enhanced sonography of the spleen. Semin Ultrasound CT MR. 2006;27(5):426–33.CrossRefPubMed
66.
Zhou X, et al. Characterization and diagnostic confidence of contrast-enhanced ultrasound for solid renal tumors. Ultrasound Med Biol. 2011;37(6):845–53.CrossRefPubMed
67.
D'Onofrio M, et al. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol. 2012;81(4):630–8.CrossRefPubMed
68.
Keane PA, Sadda SR. Retinal imaging in the twenty-first century: state of the art and future directions. Ophthalmology. 2014;121(12):2489–500.CrossRefPubMed
69.
Gupta M, S L. Current and Evolving Uses of Optical Coherence Tomography in the Genitourinary Tract. Current Urology Reports. 2015;16(3)
70.
L S. New developments in optical coherence tomography. Acta Ophthalmol. 2012:90.
71.
Taruttis A, van Dam GM, Ntziachristos V. Mesoscopic and macroscopic optoacoustic imaging of cancer. Cancer Res. 2015;75(8):1548–59.CrossRefPubMed
72.
Razansky D, Buehler A, Ntziachristos V. Volumetric real-time multispectral optoacoustic tomography of biomarkers. Nat Protoc. 2011;6(8):1121–9.CrossRefPubMed
73.
Heijblom M, et al. Visualizing breast cancer using the Twente photoacoustic mammoscope: what do we learn from twelve new patient measurements? Opt Express. 2012;20(11):11582–97.CrossRefPubMed
74.
75.
Yang JM, et al. Simultaneous functional photoacoustic and ultrasonic endoscopy of internal organs in vivo. Nat Med. 2012;18(8):1297–302.CrossRefPubMed
76.
77.
Maher NG, et al. In vivo confocal microscopy for the oral cavity: current state of the field and future potential. Oral Oncol. 2016;54:28–35.CrossRefPubMed
78.
Que SK, et al. Through the looking glass: basics and principles of reflectance confocal microscopy. J Am Acad Dermatol. 2015;73(2):276–84.CrossRefPubMed
79.
Erie JC, McLaren JW, Patel SV. Confocal microscopy in ophthalmology. Am J Ophthalmol. 2009;148(5):639–46.CrossRefPubMed
80.
Ibrahim O, Gastman B, Zhang A. Advances in diagnosis and treatment of nonmelanoma skin cancer. Ann Plast Surg. 2014;73(5):615–9.CrossRefPubMed
81.
Cuneo KC, et al. Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents. Int J Radiat Oncol Biol Phys. 2013;86(1):136–42.CrossRefPubMedPubMedCentral
82.
Davies Cde L, et al. Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts. Cancer Res. 2004;64(2):547–53.CrossRefPubMed
83.
Ling CC, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47(3):551–60.CrossRefPubMed
84.
Grégoire V, M T. State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83). Cancer Radiotherapy. 2011;15:555–9.CrossRef
85.
Schutze C, et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother Oncol. 2007;83(3):311–5.CrossRefPubMed
86.
87.
Duprez F, et al. Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80(4):1045–55.CrossRefPubMed
88.
Metadata
Title
Upcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology
Authors
Paul Russell Roberts
Ashesh B. Jani
Satyaseelan Packianathan
Ashley Albert
Rahul Bhandari
Srinivasan Vijayakumar
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2018
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-018-1091-1

Other articles of this Issue 1/2018

Radiation Oncology 1/2018 Go to the issue

Research

Dosimetric analysis of tangent-based volumetric modulated arc therapy with deep inspiration breath-hold technique for left breast cancer patients

Research

Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database

Research

LINAC stereotactic radiosurgery for trigeminal neuralgia –retrospective two-institutional examination of treatment outcomes

Research

Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis

Short report

Quality improvement program in radiation oncology: understanding patient hospitalizations, treatment breaks, and weight loss in patients receiving radiotherapy

Research

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?